Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chemotherapy Effect
Interventions: DRUG: Nab paclitaxel|DRUG: Docetaxel
Sponsor: Xuli Meng